吹牛逼，说好2期数据_老虎社区_美港股上老虎

赢击长空
2023-11-17

吹牛逼，说好2期数据呢

Vaccitech rebrands as Barinthus, plans to present data at AASLD meeting

Vaccitech said that it has rebranded at Barinthus Biotherapeutics to reflect its expansion beyond developing vaccines. Barinthus shares will begin trading on Nasdaq under the symbol BRNS on Tuesday, Nov. 7. The company added that it plans to present Phase 2 data on its drug candidate VTP-300 in the treatment of patients with chronic hepatitis B at The American Association for the Study of Liver Diseases, or AASLD, to be held Nov. 10-14 in Boston. More on Vaccitech Vaccitech surges despite Morgan Stanley downgrade Seeking Alpha’s Quant Rating on Vaccitech Historical earnings data for Vaccitech Financial information for Vaccitech

Vaccitech rebrands as Barinthus, plans to present data at AASLD meeting

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":242523373674776,"tweetId":"242523373674776","gmtCreate":1700231026773,"gmtModify":1700231127716,"author":{"id":3550916429756056,"authorId":3550916429756056,"authorIdStr":"3550916429756056","name":"赢击长空","avatar":"https://static.tigerbbs.com/d67d618b2a23c914580657c77ce712c1","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.19","exceedPercentage":"93.01%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>吹牛逼，说好2期数据呢</p></body></html>","htmlText":"<html><head></head><body><p>吹牛逼，说好2期数据呢</p></body></html>","text":"吹牛逼，说好2期数据呢","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/242523373674776","repostId":2381014751,"repostType":2,"repost":{"id":"2381014751","pubTimestamp":1699288734,"share":"https://www.laohu8.com/m/news/2381014751?lang=&edition=full","pubTime":"2023-11-07 00:38","market":"us","language":"en","title":"Vaccitech rebrands as Barinthus, plans to present data at AASLD meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2381014751","media":"seekingalpha","summary":"Vaccitech  said that it has rebranded at Barinthus Biotherapeutics  to reflect its expansion beyond developing vaccines. Barinthus shares will begin trading on Nasdaq under the symbol BRNS on Tuesday, Nov. 7. The company added that it plans to present Phase 2 data on its drug candidate VTP-300 in the treatment of patients with chronic hepatitis B at The American Association for the Study of Liver Diseases, or AASLD, to be held Nov. 10-14 in Boston.   More on Vaccitech  Vaccitech surges despite Morgan Stanley downgrade Seeking Alpha’s Quant Rating on Vaccitech Historical earnings data for Vaccitech Financial information for Vaccitech","content":"<html><body><p>Vaccitech (<span>NASDAQ:VACC</span>) said that it has rebranded at Barinthus Biotherapeutics (BRNS) to reflect its expansion beyond developing vaccines.</p> <p>Barinthus shares will begin trading on Nasdaq under the symbol BRNS on Tuesday, Nov. 7.</p> <p>The company added that it plans to<span> present Phase 2 data on its drug candidate VTP-300 in the treatment of patients with chronic hepatitis B at The American Association for the Study of Liver Diseases, or AASLD, to be held Nov. 10-14 in Boston. </span></p> <div> <h2>More on Vaccitech</h2> <ul> <li>Vaccitech surges despite Morgan Stanley downgrade</li> <li>Seeking Alpha’s Quant Rating on Vaccitech</li> <li>Historical earnings data for Vaccitech</li> <li>Financial information for Vaccitech</li> </ul> </div></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccitech rebrands as Barinthus, plans to present data at AASLD meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccitech rebrands as Barinthus, plans to present data at AASLD meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-11-07 00:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4031008-vaccitech-rebrands-as-barinthus-plans-to-present-data-at-aasld-meeting><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Vaccitech (NASDAQ:VACC) said that it has rebranded at Barinthus Biotherapeutics (BRNS) to reflect its expansion beyond developing vaccines. Barinthus shares will begin trading on Nasdaq under the ...</p>\n\n<a href=\"https://seekingalpha.com/news/4031008-vaccitech-rebrands-as-barinthus-plans-to-present-data-at-aasld-meeting\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/977304138/image_977304138.jpg","relate_stocks":{"BK4588":"碎股","QID":"纳指两倍做空ETF",".IXIC":"NASDAQ Composite","LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","BK4581":"高盛持仓","BK4504":"桥水持仓","PSQ":"纳指反向ETF","TQQQ":"纳指三倍做多ETF","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","QLD":"纳指两倍做多ETF","BK4127":"投资银行业与经纪业","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU0106831901.USD":"贝莱德世界金融基金A2","QQQ":"纳指100ETF","SQQQ":"纳指三倍做空ETF","BK4539":"次新股","BRNS":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON","LU0971096721.USD":"富达环球金融服务 A","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","BK4139":"生物科技","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","MS":"摩根士丹利"},"source_url":"https://seekingalpha.com/news/4031008-vaccitech-rebrands-as-barinthus-plans-to-present-data-at-aasld-meeting","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2381014751","content_text":"Vaccitech (NASDAQ:VACC) said that it has rebranded at Barinthus Biotherapeutics (BRNS) to reflect its expansion beyond developing vaccines. Barinthus shares will begin trading on Nasdaq under the symbol BRNS on Tuesday, Nov. 7. The company added that it plans to present Phase 2 data on its drug candidate VTP-300 in the treatment of patients with chronic hepatitis B at The American Association for the Study of Liver Diseases, or AASLD, to be held Nov. 10-14 in Boston.   More on Vaccitech  Vaccitech surges despite Morgan Stanley downgrade Seeking Alpha’s Quant Rating on Vaccitech Historical earnings data for Vaccitech Financial information for Vaccitech","news_type":1},"isVote":1,"tweetType":1,"viewCount":426,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":20,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}